Home Markets Kennedy’s new US vaccine panel backs Merck’s RSV drug for infants

Kennedy’s new US vaccine panel backs Merck’s RSV drug for infants

Jun 26, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/kennedys-us-vaccine-panel-votes-in-favor-of-mercks-rsv-antibody-drug-4113185

You May Also Like

Terns Pharmaceuticals gets FDA breakthrough status for leukemia drug

Compass Therapeutics stock plunges on trial data concerns, William Blair comments

FTSE 100: Stocks trade higher as Iran offers Hormuz deal ahead of nuclear talks

Organon soars 15% after India’s Sun Pharma strikes $11.8bn takeover deal

Indonesia stocks higher at close of trade; IDX Composite Index up 0.04%

Deutsche Bank sees room for equity positioning to climb higher